Search alternatives:
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
13841
Table_3_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.DOCX
Published 2022“…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
-
13842
Table_9_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.XLSX
Published 2022“…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
-
13843
Table_5_Pathogenesis of Enamel-Renal Syndrome Associated Gingival Fibromatosis: A Proteomic Approach.pdf
Published 2021“…<p>The enamel renal syndrome (ERS) is a rare disorder featured by amelogenesis imperfecta, gingival fibromatosis and nephrocalcinosis. …”
-
13844
Table_1_Pathogenesis of Enamel-Renal Syndrome Associated Gingival Fibromatosis: A Proteomic Approach.docx
Published 2021“…<p>The enamel renal syndrome (ERS) is a rare disorder featured by amelogenesis imperfecta, gingival fibromatosis and nephrocalcinosis. …”
-
13845
Table_7_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.DOCX
Published 2022“…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
-
13846
Table_5_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.DOCX
Published 2022“…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
-
13847
Table_6_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.XLSX
Published 2022“…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
-
13848
Table_2_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.XLSX
Published 2022“…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
-
13849
Table_6_Pathogenesis of Enamel-Renal Syndrome Associated Gingival Fibromatosis: A Proteomic Approach.pdf
Published 2021“…<p>The enamel renal syndrome (ERS) is a rare disorder featured by amelogenesis imperfecta, gingival fibromatosis and nephrocalcinosis. …”
-
13850
Data_Sheet_3_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu...
Published 2022“…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
-
13851
Data_Sheet_8_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu...
Published 2022“…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
-
13852
Data_Sheet_9_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu...
Published 2022“…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
-
13853
Table_1_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfunctio...
Published 2022“…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
-
13854
Data_Sheet_2_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.PDF
Published 2022“…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
-
13855
Data_Sheet_2_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu...
Published 2022“…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
-
13856
Data_Sheet_1_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.PDF
Published 2022“…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
-
13857
Table_2_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfunctio...
Published 2022“…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
-
13858
Data_Sheet_6_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu...
Published 2022“…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
-
13859
Data_Sheet_4_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu...
Published 2022“…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
-
13860
Data_Sheet_3_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.PDF
Published 2022“…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”